Cargando…
Tacrolimus Prevents TWEAK-Induced PLA2R Expression in Cultured Human Podocytes
Primary membranous nephropathy is usually caused by antibodies against the podocyte antigen membrane M-type phospholipase A2 receptor (PLA2R). The treatment of membranous nephropathy is not fully satisfactory. The calcineurin inhibitor tacrolimus is used to treat membranous nephropathy, but recurren...
Autores principales: | Cuarental, Leticia, Valiño-Rivas, Lara, Mendonça, Luis, Saleem, Moin, Mezzano, Sergio, Sanz, Ana Belen, Ortiz, Alberto, Sanchez-Niño, Maria Dolores |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408934/ https://www.ncbi.nlm.nih.gov/pubmed/32664235 http://dx.doi.org/10.3390/jcm9072178 |
Ejemplares similares
-
TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells
por: Valiño-Rivas, Lara, et al.
Publicado: (2018) -
Non-canonical NFκB activation promotes chemokine expression in podocytes
por: Valiño-Rivas, Lara, et al.
Publicado: (2016) -
TWEAK Promotes Peritoneal Inflammation
por: Sanz, Ana Belen, et al.
Publicado: (2014) -
CD74 in Kidney Disease
por: Valiño-Rivas, Lara, et al.
Publicado: (2015) -
Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease
por: Trimarchi, Hernán, et al.
Publicado: (2017)